Literature DB >> 17966790

[Lung cancer. Epidemiology and etiologic factors].

N Frusch1, L Bosquée, R Louis.   

Abstract

Lung cancer is the most frequent cause of death by cancer worldwide. Despite improvements in the treatment the vital prognosis remains poor with an estimated 5-year survival rate of 15 % all stages together. Even if some environmental exposure may favour apparition of the disease, tobacco smoking is by far the greatest risk factor for developing lung cancer. Recent progresses have been made on the identification of cellular mechanisms and genetic abnormalities that make the patients more prone to develop lung cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17966790

Source DB:  PubMed          Journal:  Rev Med Liege        ISSN: 0370-629X


  7 in total

1.  Neuronal acetylcholine receptor subunit alpha-9 (CHRNA9) polymorphisms are associated with NSCLC risk in a Chinese population.

Authors:  Ying Wang; Yongjun Zhang; Cuiping Gu; Wenlong Bao; Yejiang Bao
Journal:  Med Oncol       Date:  2014-03-28       Impact factor: 3.064

2.  CHRNA3 genetic polymorphism and the risk of lung cancer in the Chinese Han smoking population.

Authors:  Wenjing Zhou; Tingting Geng; Huijuan Wang; Xiaojie Xun; Tian Feng; Hui Zou; Longli Kang; Tianbo Jin; Chao Chen
Journal:  Tumour Biol       Date:  2015-02-06

3.  Polymorphisms of CHRNA5-CHRNA3-CHRNB4 Gene Cluster and NSCLC Risk in Chinese Population.

Authors:  Zhijun Li; Suzhen Bao; Xiaohong Xu; Yejiang Bao; Yongjun Zhang
Journal:  Transl Oncol       Date:  2012-12-01       Impact factor: 4.243

4.  Comparison of single-agent chemotherapy and targeted therapy to first-line treatment in patients aged 80 years and older with advanced non-small-cell lung cancer.

Authors:  Qianqian Zhang; Zhehai Wang; Jun Guo; Liyan Liu; Xiao Han; Minmin Li; Shu Fang; Xiang Bi; Ning Tang; Yang Liu
Journal:  Onco Targets Ther       Date:  2015-04-20       Impact factor: 4.147

5.  Low-density lipoprotein receptor-related protein 6 (LRP6) rs10845498 polymorphism is associated with a decreased risk of non-small cell lung cancer.

Authors:  Dehou Deng; Yongjun Zhang; Wenglong Bao; Xiangming Kong
Journal:  Int J Med Sci       Date:  2014-05-02       Impact factor: 3.738

6.  [cDNA microarray technique on screening multi-drug resistance-related genes of human non-small cell lung cancer].

Authors:  Meiyan Liu; Chunhong Li; An Yan; Li Cai
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-04

7.  Two novel susceptibility loci for non-small cell lung cancer map to low-density lipoprotein receptor-related protein 5.

Authors:  Ying Wang; Yongjun Zhang; Meiyu Fang; Wenglong Bao; Dehou Deng
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.